Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

Clinical trial NCT06226805 · RECRUITING

Trial details

NCT number: NCT06226805
Sponsor: Basking Biosciences, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2024-07-31
Primary completion: 2027-06-01
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.